182 related articles for article (PubMed ID: 15225438)
1. [Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
Gu XB; Chen HK; Zhu YF; Pei H; Liu XY
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):370. PubMed ID: 15225438
[No Abstract] [Full Text] [Related]
2. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis.
Sansoé G; Silvano S; Mengozzi G; Todros L; Smedile A; Touscoz G; Rosina F; Rizzetto M
J Hepatol; 2004 Mar; 40(3):417-23. PubMed ID: 15123355
[TBL] [Abstract][Full Text] [Related]
3. [Renal perfusion and the renin-angiotensin system in hepatic cirrhosis].
Bosch Y; Arroyo V; Mauri M; Rivera F; Rodes J
Minerva Med; 1978 Oct; 69(47):3249-55. PubMed ID: 714306
[No Abstract] [Full Text] [Related]
4. [Determination of plasma renin activity in edematous cirrhosis. Influence of various depletive treatments].
Cottin S; Miniconi P; Belet JL; Cadudal JL; Talmant JC; Bailleux A
Sem Hop; 1973 Apr; 49(19):1357-63. PubMed ID: 4355382
[No Abstract] [Full Text] [Related]
5. Deranged renal function in liver disease.
Epstien M
Contrib Nephrol; 1977; 7():250-71. PubMed ID: 330107
[No Abstract] [Full Text] [Related]
6. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.
Bosch J; Arroyo V; Betriu A; Mas A; Carrilho F; Rivera F; Navarro-Lopez F; Rodes J
Gastroenterology; 1980 Jan; 78(1):92-9. PubMed ID: 7350041
[No Abstract] [Full Text] [Related]
7. Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion.
Wong PY; Carroll RE; Lipinski TL; Capone RR
Gastroenterology; 1979 Dec; 77(6):1171-6. PubMed ID: 499705
[No Abstract] [Full Text] [Related]
8. [Neurohumoral activity in liver cirrhosis].
Lazúrová I; Rosochová I; Lichardus B; Trejbal D; Hildebrand T; Tkác I; Machánová Y; Murár J
Vnitr Lek; 1995 Oct; 41(10):667-71. PubMed ID: 8578696
[TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin-aldosterone in cirrhotic ascites.
Martin A; Sturniolo GC; Naccarato R
Gastroenterology; 1980 May; 78(5 Pt 1):1122-3. PubMed ID: 6991356
[No Abstract] [Full Text] [Related]
10. The influence of upright position and sodium restriction in the diet on plasma renin activity (PRA) and aldosteronemia in patients with chronic nephritis.
Kuska J; Kokot F; Libera T; Sledziński Z
Mater Med Pol; 1977; 9(4):312-7. PubMed ID: 599962
[No Abstract] [Full Text] [Related]
11. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
Sansoè G; Silvano S; Rosina F; Smedile A; Rizzetto M
J Intern Med; 2005 Apr; 257(4):358-66. PubMed ID: 15788006
[TBL] [Abstract][Full Text] [Related]
12. Renal failure in advanced liver disease.
Baldus WP
Prog Liver Dis; 1972; 4():251-67. PubMed ID: 4347066
[No Abstract] [Full Text] [Related]
13. Acute effects of saralasin on plasma aldosterone in different pathophysiological conditions.
Anderson GH; Anderson T; Streeten DH; Schroeder ET
J Clin Endocrinol Metab; 1980 Mar; 50(3):529-36. PubMed ID: 6987256
[No Abstract] [Full Text] [Related]
14. [Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis].
Ikebe H; Hoashi S; Irie F; Taniguchi K; Honda N; Mitarai Y; Kobayashi N
Masui; 1988 May; 37(5):546-51. PubMed ID: 3045361
[No Abstract] [Full Text] [Related]
15. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
Arbeiter G; Meyer-Burg J
Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
[No Abstract] [Full Text] [Related]
17. [Renal insufficiency in decompensated liver cirrhosis. Report of 5 cases and a review of the pathophysiology].
Thomsen AC
Ugeskr Laeger; 1968 Apr; 130(14):585-91. PubMed ID: 4303382
[No Abstract] [Full Text] [Related]
18. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
[TBL] [Abstract][Full Text] [Related]
19. [The renin-angiotensin-aldosterone system in chronic diseases of the liver].
Loginov AS; Khodarev NN; Astaf'eva OV
Sov Med; 1988; (4):9-11. PubMed ID: 3043716
[No Abstract] [Full Text] [Related]
20. Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease.
Sellars L; Shore AC; Wilkinson R; James OF; Robson V
Eur J Clin Invest; 1981 Aug; 11(4):299-304. PubMed ID: 6795046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
